EGFR and neoplasm: Bioluminescent images and hematoxylin and eosin (H&E) staining demonstrated that loss of NFAT5 significantly abrogated EGFR-driven tumor growth and enhanced the sensitivity of tumors to TMZ (Fig. 2h, i).